76 related articles for article (PubMed ID: 3921841)
1. Implications of hepatic and extrahepatic metabolism of aspirin in selective inhibition of platelet cyclooxygenase.
Roberts MS; Cossum PA; Kilpatrick D
N Engl J Med; 1985 May; 312(21):1388-9. PubMed ID: 3921841
[No Abstract] [Full Text] [Related]
2. Inhibition of platelet prostaglandin synthetase by oral aspirin.
Burch JW; Stanford N; Majerus PW
J Clin Invest; 1978 Feb; 61(2):314-9. PubMed ID: 413839
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of platelet cyclooxygenase by aspirin-like drugs: methods for in vitro and ex vivo assessment.
Patrono C; Ciabattoni G; Pugliese F; Pinca E; Castrucci G; De Salvo A; Satta MA; Parachini M
Agents Actions Suppl; 1979; (4):138-46. PubMed ID: 115255
[No Abstract] [Full Text] [Related]
4. Low-dose aspirin is a selective inhibitor of platelet cyclooxygenase activity in healthy subjects.
Patrignani P; Filabozzi P; Patrono C
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():259-64. PubMed ID: 6221533
[No Abstract] [Full Text] [Related]
5. Arachidonic acid metabolism and inhibition of cyclooxygenase in platelets from asthmatic subjects with aspirin intolerance.
Bonne C; Moneret-Vautrin DA; Wayoff M; Descharmes A; Gazel P; Legrand A; Kalt C
Ann Allergy; 1985 Feb; 54(2):158-60. PubMed ID: 3918485
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
[TBL] [Abstract][Full Text] [Related]
7. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase.
Pedersen AK; FitzGerald GA
N Engl J Med; 1984 Nov; 311(19):1206-11. PubMed ID: 6436696
[TBL] [Abstract][Full Text] [Related]
8. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
Schrör K
Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in cyclooxygenase 1: effects on response to aspirin.
Halushka MK; Walker LP; Halushka PV
Clin Pharmacol Ther; 2003 Jan; 73(1):122-30. PubMed ID: 12545150
[TBL] [Abstract][Full Text] [Related]
10. Interference by sulfinpyrazone and salicylate of aspirin inhibition of platelet cyclooxygenase activity.
Ali M; McDonald JW
Prostaglandins Med; 1979 Dec; 3(6):327-32. PubMed ID: 121613
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases.
Patrignani P; Panara MR; Greco A; Fusco O; Natoli C; Iacobelli S; Cipollone F; Ganci A; Créminon C; Maclouf J
Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():129-31. PubMed ID: 7732817
[No Abstract] [Full Text] [Related]
12. Salicylamide reverses the aspirin-antagonistic effect of salicylic acid on rat platelet cyclooxygenase.
Rizk M; Abdel-Rahman MS
Prostaglandins Leukot Essent Fatty Acids; 1994 Nov; 51(5):363-7. PubMed ID: 7846108
[TBL] [Abstract][Full Text] [Related]
13. Comparison of effects of aspirin and indomethacin on human platelet prostaglandin synthetase.
Crook D; Collins AJ
Ann Rheum Dis; 1977 Oct; 36(5):459-63. PubMed ID: 411427
[TBL] [Abstract][Full Text] [Related]
14. Enteric-coated aspirin, platelet cyclooxygenase activity and function.
Rao GH; Radh E; Johnson GJ; White JG
Prostaglandins Leukot Med; 1984 Mar; 13(3):341-7. PubMed ID: 6425869
[TBL] [Abstract][Full Text] [Related]
15. Tramadol anti-inflammatory activity is not related to a direct inhibitory action on prostaglandin endoperoxide synthases.
Buccellati C; Sala A; Ballerio R; Bianchib M
Eur J Pain; 2000; 4(4):413-5. PubMed ID: 11124014
[TBL] [Abstract][Full Text] [Related]
16. Low-dose enteric-coated aspirin: a practical approach to continuous-release low-dose aspirin and presystemic acetylation of human platelet cyclooxygenase.
Jakubowski JA; Stampfer MJ; Vaillancourt R; Faigel D; Deykin D
J Lab Clin Med; 1986 Dec; 108(6):616-21. PubMed ID: 3097223
[TBL] [Abstract][Full Text] [Related]
17. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
[TBL] [Abstract][Full Text] [Related]
18. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of aspirin in the long-term management of atherothrombosis.
Patrono C
Haematologica; 2002 Jan; 87(1):6-8. PubMed ID: 11801459
[No Abstract] [Full Text] [Related]
20. Towards a better aspirin.
Vane J
Nature; 1994 Jan; 367(6460):215-6. PubMed ID: 8121485
[No Abstract] [Full Text] [Related]
[Next] [New Search]
